Cancer–stroma interactions as a target for cancer treatment.
During tumor evolution, cancer cells use the tumor-stroma crosstalk to reorganize the microenvironment for maximum robustness of tumor. The success of immune checkpoint therapy generates a new cancer therapy paradigm: an effective cancer treatment should not aim to influence the individual component...
Збережено в:
| Дата: | 2018 |
|---|---|
| Автори: | , , |
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
2018
|
| Назва видання: | Інститут молекулярної біології і генетики НАН України |
| Теми: | |
| Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/154273 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Цитувати: | Cancer–stroma interactions as a target for cancer treatment. / I.V. Alekseenko, V.V. Pleshkan, E.D. Sverdlov // Вiopolymers and Cell. — 2018. — Т. 34, № 4. — С. 271-283. — Бібліогр.: 69 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraine| Резюме: | During tumor evolution, cancer cells use the tumor-stroma crosstalk to reorganize the microenvironment for maximum robustness of tumor. The success of immune checkpoint therapy generates a new cancer therapy paradigm: an effective cancer treatment should not aim to influence the individual components of super complex intracellular interactomes (molecular targeting), but rather to disrupt the intercellular interactions between cancer and stromal cells, thus breaking the tumor as a whole. In this minireview we consider cancer associated fibroblasts (CAF) and their interactions with cancer cells as a promising direction for cancer therapy. |
|---|